Primary Sclerosing Cholangitis: Clinical Trials

17 trials for Primary Sclerosing Cholangitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 3 recruiting, 2 terminated, 1 unknown. 17 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 117Completed 10, Recruiting 3, Terminated 2, Unknown 1, Withdrawn 1
Phase 23Completed 1, Terminated 1, Unknown 1

Follow Primary Sclerosing Cholangitis: new trials by email Literature Review of Primary Sclerosing Cholangitis trials Research Report on Primary Sclerosing Cholangitis

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)
TAK-781, Placebo - Healthy Volunteers, Primary Sclerosing Cholangitis
Phase 1RecruitingTakeda1342026-01-072026-03-05
A Study of SIPLIZUMAB in AILD and LT Patients
Siplizumab - Autoimmune Liver Disease, Liver Transplant Disorder
Phase 1RecruitingElizabeth C. Verna82024-09-112025-11-24
Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis
Cilofexor - Primary Sclerosing Cholangitis, Compensated Cirrhosis
Phase 1TerminatedGilead Sciences112019-10-172023-07-27
A Study Of Ursolic Acid For Primary Sclerosing Cholangitis
Ursolic acid - Primary Sclerosing Cholangitis
Phase 1WithdrawnUniversity of California, Davis2017-09-012017-07-25
A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC)
Curcumin - Primary Sclerosing Cholangitis
Phase 1 / Phase 2CompletedJohn E. Eaton152017-06-092020-01-18
A Study of HTD1801 in Healthy Subjects
HTD1801 - Primary Sclerosing Cholangitis
Phase 1CompletedHighTide Therapeutics (Hong Kong) Limited322017-03-242026-08-11
Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis
UCMSC, UDCA - Primary Sclerosing Cholangitis
Phase 1 / Phase 2UnknownFuzhou General Hospital202017-01-012018-05-04
A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
Vancomycin - Primary Sclerosing Cholangitis, Inflammatory Bowel Disease
Phase 1CompletedUniversity of Minnesota82015-07-012020-07-17
Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT
11C-CSar, ICG - Cholestasis, Primary Sclerosing Cholangitis
Phase 1CompletedUniversity of Aarhus222013-06-012015-02-23
Pilot Study of Fenofibrate for PSC
fenofibrate - Primary Sclerosing Cholangitis
Phase 1 / Phase 2TerminatedUniversity of Miami82010-10-012018-02-06
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
ursodeoxycholic acid (UDCA) - Primary Sclerosing Cholangitis
Phase 1CompletedUniversity of Tennessee272010-10-012017-10-26
Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Oral Vancomycin - Primary Sclerosing Cholangitis, Biliary Atresia
Phase 1RecruitingSacramento Pediatric Gastroenterology2002010-07-012016-11-15
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
Vancomycin, Metronidazole - Primary Sclerosing Cholangitis
Phase 1CompletedMayo Clinic352010-02-012013-09-19
Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
Erlotinib (Tarceva) - Primary Sclerosing Cholangitis, Trisomy 7
Phase 1CompletedMayo Clinic62009-08-012014-01-10
Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Vancomycin - Primary Sclerosing Cholangitis, Biliary Atresia
Phase 1CompletedStanford University322007-05-012016-05-18
Evaluation of DHA for the Treatment of PSC
Docosahexaenoic Acid (DHA) - Primary Sclerosing Cholangitis, Colitis
Phase 1CompletedBeth Israel Deaconess Medical Center102005-12-012015-03-11
Minocycline in Primary Sclerosing Cholangitis (PSC)
Minocycline - Primary Sclerosing Cholangitis
Phase 1CompletedMayo Clinic162003-02-012010-12-07

Narrower conditions

Cholangitis, Sclerosing (17)  ·  Biliary Atresia (2)  ·  Hepatitis, Autoimmune (2)  ·  Cholangiocarcinoma (1)  ·  Cholestasis (1)  ·  Colitis (1)  ·  End Stage Liver Disease (1)  ·  Fibrosis (1)  ·  Inflammatory Bowel Diseases (1)  ·  Liver Cirrhosis (1)  ·  Liver Cirrhosis, Biliary (1)

Broader conditions

Bile Duct Diseases (17)  ·  Biliary Tract Diseases (17)  ·  Cholangitis (17)  ·  Digestive System Diseases (17)  ·  Liver Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Autoimmune Diseases (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Digestive System Abnormalities (2)  ·  Fibrosis (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Hepatitis (2)

Interventions

Vancomycin (4)  ·  Curcumin (1)  ·  Docosahexaenoic Acids (1)  ·  Erlotinib Hydrochloride (1)  ·  Fenofibrate (1)  ·  Fish Oils (1)  ·  Indocyanine Green (1)  ·  Metronidazole (1)  ·  Minocycline (1)  ·  Ursodeoxycholic Acid (1)  ·  Ursolic Acid (1)  ·  cholylsarcosine (1)  ·  cilofexor (1)  ·  siplizumab (1)

Sponsors

Mayo Clinic (3)  ·  Beth Israel Deaconess Medical Center (1)  ·  Elizabeth C. Verna (1)  ·  Fuzhou General Hospital (1)  ·  Gilead Sciences (1)  ·  HighTide Therapeutics (Hong Kong) Limited (1)  ·  John E. Eaton (1)  ·  Sacramento Pediatric Gastroenterology (1)  ·  Stanford University (1)  ·  Takeda (1)  ·  University of Aarhus (1)  ·  University of California, Davis (1)  ·  University of Miami (1)  ·  University of Minnesota (1)  ·  University of Tennessee (1)

Countries

United States (13)  ·  Australia (1)  ·  Denmark (1)

Top investigators

Benjamin Shneider, M.D. (1)  ·  Byron P Vaughn, MD (1)  ·  Christopher Bowlus, MD (1)  ·  Cynthia Levy, MD (1)  ·  Dennis D Black, M.D. (1)  ·  Elizabeth Verna, MD (1)  ·  Janet Wong, Doctor (1)  ·  Jayant A Talwalkar, MD (1)  ·  Keith D. Lindor, M.D. (1)  ·  Kenneth L Cox, MD (1)  ·  Nicholas F LaRusso, M.D. (1)  ·  Steve D Freedman, MD, PhD (1)  ·  Susanne Keiding, M.D. D.Sc. (1)

Results publications

PMID 23054338, PMID 23384404, PMID 28249726, PMID 32633158, PMID 38976363

NIH funding

R03DK071851 (1)